Literature DB >> 17002283

Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: self-association analysis and nucleic acid binding characterization.

Haibin Luo1, Jing Chen, Kaixian Chen, Xu Shen, Hualiang Jiang.   

Abstract

Coronavirus nucleocapsid (N) protein envelops the genomic RNA to form long helical nucleocapsid during virion assembly. Since N protein oligomerization is usually a crucial step in this process, characterization of such an oligomerization will help in the understanding of the possible mechanisms for nucleocapsid formation. The N protein of severe acute respiratory syndrome coronavirus (SARS-CoV) was recently discovered to self-associate by its carboxyl terminus. In this study, to further address the detailed understanding of the association feature of this C-terminus, its oligomerization was systematically investigated by size exclusion chromatography and chemical cross-linking assays. Our results clearly indicated that the C-terminal domain of SARS-CoV N protein could form not only dimers but also trimers, tetramers, and hexamers. Further analyses against six deletion mutants showed that residues 343-402 were necessary and sufficient for this C-terminus oligomerization. Although this segment contains many charged residues, differences in ionic strength have no effects on its oligomerization, indicating the absence of electrostatic force in SARS-CoV N protein C-terminus self-association. Gel shift assay results revealed that the SARS-CoV N protein C-terminus is also able to associate with nucleic acids and residues 363-382 are the responsible interaction partner, demonstrating that this fragment might involve genomic RNA binding sites. The fact that nucleic acid binding could promote the SARS-CoV N protein C-terminus to form high-order oligomers implies that the oligomeric SARS-CoV N protein probably combines with the viral genomic RNA in triggering long nucleocapsid formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17002283     DOI: 10.1021/bi0609319

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

1.  The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.

Authors:  Yong Hu; Wei Li; Ting Gao; Yan Cui; Yanwen Jin; Ping Li; Qingjun Ma; Xuan Liu; Cheng Cao
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

2.  Recognition of the murine coronavirus genomic RNA packaging signal depends on the second RNA-binding domain of the nucleocapsid protein.

Authors:  Lili Kuo; Cheri A Koetzner; Kelley R Hurst; Paul S Masters
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

3.  The Nucleocapsid Protein of Coronaviruses Acts as a Viral Suppressor of RNA Silencing in Mammalian Cells.

Authors:  Lei Cui; Haiying Wang; Yanxi Ji; Jie Yang; Shan Xu; Xingyu Huang; Zidao Wang; Lei Qin; Po Tien; Xi Zhou; Deyin Guo; Yu Chen
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

4.  Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein.

Authors:  Renjie Zhou; Rui Zeng; Albrecht von Brunn; Jian Lei
Journal:  Mol Biomed       Date:  2020-08-06

5.  Multiple nucleic acid binding sites and intrinsic disorder of severe acute respiratory syndrome coronavirus nucleocapsid protein: implications for ribonucleocapsid protein packaging.

Authors:  Chung-Ke Chang; Yen-Lan Hsu; Yuan-Hsiang Chang; Fa-An Chao; Ming-Chya Wu; Yu-Shan Huang; Chin-Kun Hu; Tai-Huang Huang
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

6.  Identification of in vivo-interacting domains of the murine coronavirus nucleocapsid protein.

Authors:  Kelley R Hurst; Cheri A Koetzner; Paul S Masters
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

7.  mRNA display design of fibronectin-based intrabodies that detect and inhibit severe acute respiratory syndrome coronavirus nucleocapsid protein.

Authors:  Hsiang-I Liao; C Anders Olson; Seungmin Hwang; Hongyu Deng; Elaine Wong; Ralph S Baric; Richard W Roberts; Ren Sun
Journal:  J Biol Chem       Date:  2009-04-13       Impact factor: 5.157

8.  Elucidation of the stability and functional regions of the human coronavirus OC43 nucleocapsid protein.

Authors:  Chun-Yu Huang; Yen-Lan Hsu; Wan-Ling Chiang; Ming-Hon Hou
Journal:  Protein Sci       Date:  2009-11       Impact factor: 6.725

Review 9.  The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation.

Authors:  Zhihua Bai; Ying Cao; Wenjun Liu; Jing Li
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

10.  Transient oligomerization of the SARS-CoV N protein--implication for virus ribonucleoprotein packaging.

Authors:  Chung-ke Chang; Chia-Min Michael Chen; Ming-hui Chiang; Yen-lan Hsu; Tai-huang Huang
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.